Proscia Company
Proscia is a software company that is changing the way the world practices pathology to transform cancer research and diagnosis. With the company’s Concentriq digital pathology platform and pipeline of AI-powered applications, laboratories are leveraging new kinds of data to accelerate discoveries and improve patient outcomes. Proscia’s team of technologists, scientists, and pathologists is bringing a fresh approach to an outdated industry, helping the world to keep pace with the increasing demand for pathology services and fulfill the promise of precision diagnostics.
(Reupload).png)
Technology:
Artificial Intelligence, Biotechnology, Medical, Software
Industry:
Clinical Development
Headquarters:
Philadelphia, Pennsylvania, United States
Founded Date:
2014-07-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
10
Total Funding:
33973000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-11-30
Last Funding Type:
Series B
Register and Claim Ownership